Arecor Therapeutics plc (AREC.L)
Arecor Therapeutics plc, a clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom.
61.00-0.04%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+7.0%
The outlook
Arecor Therapeutics plc currently reads as leaning bearish based on below its 50- & 200-day averages, 13% of the way from its 52-week low to high, avg target +352% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Price targetAvg target +352% vs current price
Analyst price target
~12-month · 2 analysts275.50average target+351.6% vs now
Now 61.00
Low 251.00High 300.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$23.0M
52-wk high
100.00
52-wk low
55.00
50-day avg
64.21
200-day avg
71.13
Trailing P/E
30.5